Lamisil Tablet 250mg 28's batch W0012 Package Insert (PI) non-compliance (SIN 06932P)

Novartis would like to alert healthcare professional on the distribution of a non-compliant product information (PI) leaflet that was included in a batch of Lamisil Tablet 250mg 28's (Batch W0012). Healthcare professionals are advised to discard the non-compliant PI and to refer to the approved PI for the information. Please refer to the Dear Healthcare Professional Letter for further details.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.